FRAX (Fracture Risk Assessment Tool)
iatroX editorial team · Updated · Record checked · editorial policy
FRAX estimates the 10-year probability of a major osteoporotic fracture (hip, spine, forearm, humerus) and hip fracture specifically, using clinical risk factors with or without femoral neck BMD. Country-specific models are available for >70 countries.
calculate with the official tool
Use the official calculator for this model, then return here for interpretation and related guidance.
Open the official FRAX calculator ↗evidence
derivation
Developed by Kanis et al. (2008) at the University of Sheffield from meta-analyses of prospective population-based cohorts worldwide. Published in Osteoporos Int.
validation
Validated in >1 million patient-years of follow-up across multiple countries. FRAX integrates country-specific fracture and mortality rates, making it the most internationally applicable fracture risk tool.
guideline endorsements
NICE TA160/TA161: reference FRAX for fracture risk assessment. NOGG (National Osteoporosis Guideline Group, UK): uses FRAX with UK-specific intervention thresholds. IOF (International Osteoporosis Foundation) and NOF (US) reference FRAX. SIGN 142 (Osteoporosis) references FRAX.
regional interpretation
references
- Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385-397.PMID: 18292978
- NOGG (National Osteoporosis Guideline Group). Clinical guideline for the prevention and treatment of osteoporosis. 2021.link ↗
- NICE Technology Appraisal TA464. Bisphosphonates for treating osteoporosis. 2017.link ↗